Search

everythinglearnresearchcommunity

for

Search:↓

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Elderly abuse is often by family members, and doctors, especially dermatologists, can spot it by looking for unusual injuries and malnutrition.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Finasteride may help some women with hair loss, but better options exist.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Hair loss in postmenopausal woman caused by ovarian issue.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.